Trial intelligence / Profile preview

Sedation after Caesarean delivery to prevent postpartum depression

jRCT1011250009Recruiting

Start
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Trial of propofol and dexmedetomidine in postpartum depression (PPD), postoperative pain and anxiety disorder (2 arms). Primary endpoint: ObsQoR postpartum recovery score. Started May 2025; status: recruiting.

02

Drugs

propofoldexmedetomidine
03

Conditions

postpartum depression (PPD)postoperative painanxiety disorder

Beyond the preview

Go deeper on jRCT1011250009.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1011250009.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call